首页 > 最新文献

Diagnostics最新文献

英文 中文
Impact of Extended Membrane Rupture on Neonatal Inflammatory Responses and Composite Neonatal Outcomes in Early-Preterm Neonates-A Prospective Study.
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-18 DOI: 10.3390/diagnostics15020213
Maura-Adelina Hincu, Liliana Gheorghe, Luminita Paduraru, Daniela-Cristina Dimitriu, Anamaria Harabor, Ingrid-Andrada Vasilache, Iustina Solomon-Condriuc, Alexandru Carauleanu, Ioana Sadiye Scripcariu, Dragos Nemescu

Background/Objectives: Prolonged prelabour rupture of membranes (PROMs), and the resulting inflammatory response, can contribute to the occurrence of adverse neonatal outcomes, especially for early-preterm neonates. This prospective study aimed to measure neonates' inflammatory markers in the first 72 h of life based on ROM duration. The second aim was to examine the relationship between PROMs, serum inflammatory markers, and composite adverse neonatal outcomes after controlling for gestational age (GA). Methods: Data from 1026 patients were analyzed considering the following groups: group 1 (ROM < 18 h, n = 447 patients) and group 2 (ROM > 18 h, n = 579 patients). These groups were further segregated depending on the GA at the moment of membranes' rupture into subgroup 1 (<33 weeks of gestation and 6 days, n = 168 patients) and subgroup 2 (at least 34 completed weeks of gestation, n = 858 patients). Multiple logistic regressions and interaction analyses adjusted for GA considering five composite adverse neonatal outcomes and predictors were employed. Results: PROMs and high c-reactive protein (CRP) values significantly increased the risk of composite outcome 1 occurrence by 14% (95%CI: 1.03-1.57, p < 0.001). PROMs and high CRP values increased the risk of composite outcome 5 by 14% (95%CI: 1.07-1.78, p < 0.001), PROM and leukocytosis by 11% (95%CI: 1.02-1.59, p = 0.001), and PROMs and high PCT values by 21% (95%CI: 1.04-2.10, p < 0.001). Conclusions: The combination of PROMs and high CRP values significantly increased the risk of all evaluated adverse composite outcomes in early-preterm neonates and should point to careful monitoring of these patients.

{"title":"Impact of Extended Membrane Rupture on Neonatal Inflammatory Responses and Composite Neonatal Outcomes in Early-Preterm Neonates-A Prospective Study.","authors":"Maura-Adelina Hincu, Liliana Gheorghe, Luminita Paduraru, Daniela-Cristina Dimitriu, Anamaria Harabor, Ingrid-Andrada Vasilache, Iustina Solomon-Condriuc, Alexandru Carauleanu, Ioana Sadiye Scripcariu, Dragos Nemescu","doi":"10.3390/diagnostics15020213","DOIUrl":"10.3390/diagnostics15020213","url":null,"abstract":"<p><p><b>Background/Objectives</b>: Prolonged prelabour rupture of membranes (PROMs), and the resulting inflammatory response, can contribute to the occurrence of adverse neonatal outcomes, especially for early-preterm neonates. This prospective study aimed to measure neonates' inflammatory markers in the first 72 h of life based on ROM duration. The second aim was to examine the relationship between PROMs, serum inflammatory markers, and composite adverse neonatal outcomes after controlling for gestational age (GA). <b>Methods</b>: Data from 1026 patients were analyzed considering the following groups: group 1 (ROM < 18 h, <i>n</i> = 447 patients) and group 2 (ROM > 18 h, <i>n</i> = 579 patients). These groups were further segregated depending on the GA at the moment of membranes' rupture into subgroup 1 (<33 weeks of gestation and 6 days, <i>n</i> = 168 patients) and subgroup 2 (at least 34 completed weeks of gestation, <i>n</i> = 858 patients). Multiple logistic regressions and interaction analyses adjusted for GA considering five composite adverse neonatal outcomes and predictors were employed. <b>Results</b>: PROMs and high c-reactive protein (CRP) values significantly increased the risk of composite outcome 1 occurrence by 14% (95%CI: 1.03-1.57, <i>p</i> < 0.001). PROMs and high CRP values increased the risk of composite outcome 5 by 14% (95%CI: 1.07-1.78, <i>p</i> < 0.001), PROM and leukocytosis by 11% (95%CI: 1.02-1.59, <i>p</i> = 0.001), and PROMs and high PCT values by 21% (95%CI: 1.04-2.10, <i>p</i> < 0.001). <b>Conclusions</b>: The combination of PROMs and high CRP values significantly increased the risk of all evaluated adverse composite outcomes in early-preterm neonates and should point to careful monitoring of these patients.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"15 2","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11763809/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143037371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potentials of Presepsin as a Novel Sepsis Biomarker in Critically Ill Adults: Correlation Analysis with the Current Diagnostic Markers.
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-18 DOI: 10.3390/diagnostics15020217
Mai S Sater, Nourah Almansour, Zainab Hasan Abdulla Malalla, Salim Fredericks, Muhalab E Ali, Hayder A Giha

Background: Sepsis is a major cause of patient death in intensive care units (ICUs). Rapid diagnosis of sepsis assists in optimizing treatments and improves outcomes. Several biomarkers are employed to aid in the diagnosis, prognostication, severity grading, and sub-type discrimination of severe septic infections (SSIs), including current diagnostic parameters, hemostatic measures, and specific organ dysfunction markers. Methods: This study involved 129 critically ill adults categorized into three groups: sepsis (Se = 48), pneumonia (Pn = 48), and Se/Pn (33). Concentrations of five plasma markers (IL-6, IL-8, TREM1, uPAR, and presepsin) were compared with 13 well-established measures of SSI in critically ill patients. These measures were heart rate (HR), white blood count (WBC), C-reactive protein (CRP), procalcitonin (PCT), lactate plasma concentrations, and measures of hemostasis status (platelets count (PLT), fibrinogen, prothrombin time (PT), activated partial thromboplastin time (APTT), international normalization ratio (INR) and D-dimer). Plasma bilirubin and creatinine served as indicators of liver and kidney dysfunction, respectively. Results: Promising roles for these biomarkers were found. The best results were for presepsin, which scored 10/13, followed by IL-6 and IL-8 (each scored 7/13), and the worst were for TREM-1 and uPAR (scored 3/13). Presepsin, IL-6, and IL-8 discriminated between the SSI sub-types, whilst only presepsin correlated with bilirubin and creatinine. uPAR was positive for kidney dysfunction, and TREM-1 was the only indicator of artificial ventilation (AV). Conclusions: Presepsin is an important potential biomarker in SSIs. However, further work is needed to define this marker's diagnostic and prognostic cutoff values.

{"title":"Potentials of Presepsin as a Novel Sepsis Biomarker in Critically Ill Adults: Correlation Analysis with the Current Diagnostic Markers.","authors":"Mai S Sater, Nourah Almansour, Zainab Hasan Abdulla Malalla, Salim Fredericks, Muhalab E Ali, Hayder A Giha","doi":"10.3390/diagnostics15020217","DOIUrl":"10.3390/diagnostics15020217","url":null,"abstract":"<p><p><b>Background:</b> Sepsis is a major cause of patient death in intensive care units (ICUs). Rapid diagnosis of sepsis assists in optimizing treatments and improves outcomes. Several biomarkers are employed to aid in the diagnosis, prognostication, severity grading, and sub-type discrimination of severe septic infections (SSIs), including current diagnostic parameters, hemostatic measures, and specific organ dysfunction markers. <b>Methods:</b> This study involved 129 critically ill adults categorized into three groups: sepsis (Se = 48), pneumonia (Pn = 48), and Se/Pn (33). Concentrations of five plasma markers (IL-6, IL-8, TREM1, uPAR, and presepsin) were compared with 13 well-established measures of SSI in critically ill patients. These measures were heart rate (HR), white blood count (WBC), C-reactive protein (CRP), procalcitonin (PCT), lactate plasma concentrations, and measures of hemostasis status (platelets count (PLT), fibrinogen, prothrombin time (PT), activated partial thromboplastin time (APTT), international normalization ratio (INR) and D-dimer). Plasma bilirubin and creatinine served as indicators of liver and kidney dysfunction, respectively. <b>Results:</b> Promising roles for these biomarkers were found. The best results were for presepsin, which scored 10/13, followed by IL-6 and IL-8 (each scored 7/13), and the worst were for TREM-1 and uPAR (scored 3/13). Presepsin, IL-6, and IL-8 discriminated between the SSI sub-types, whilst only presepsin correlated with bilirubin and creatinine. uPAR was positive for kidney dysfunction, and TREM-1 was the only indicator of artificial ventilation (AV). <b>Conclusions:</b> Presepsin is an important potential biomarker in SSIs. However, further work is needed to define this marker's diagnostic and prognostic cutoff values.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"15 2","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11763968/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143037437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Analysis of Automated and Handheld Breast Ultrasound Findings for Small (≤1 cm) Breast Cancers Based on BI-RADS Category.
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-17 DOI: 10.3390/diagnostics15020212
Han Song Mun, Eun Young Ko, Boo-Kyung Han, Eun Sook Ko, Ji Soo Choi, Haejung Kim, Myoung Kyoung Kim, Jieun Kim

Objectives: This study aimed to compare ultrasound (US) findings between automated and handheld breast ultrasound (ABUS and HHUS, respectively) in small breast cancers, based on the breast imaging reporting and data system (BI-RADS) category. Methods: We included 51 women (mean age: 52 years; range: 39-66 years) with breast cancer (invasive or DCIS), all of whom underwent both ABUS and HHUS. Patients with tumors measuring ≤1 cm on either modality were enrolled. Two breast radiologists retrospectively evaluated multiple imaging features, including shape, orientation, margin, echo pattern, and posterior characteristics and assigned BI-RADS categories. Lesion sizes were compared between US and pathological findings. Statistical analyses were performed using Bowker's test of symmetry, a paired t-test, and a cumulative link mixed model. Results: ABUS assigned lower BI-RADS categories than HHUS while still maintaining malignancy suspicion in categories 4A or higher (54.8% consistent with HHUS; 37.3% downcategorized in ABUS, p = 0.005). While ABUS demonstrated less aggressive margins in some cases (61.3% consistent with HHUS; 25.8% showing fewer suspicious margins in ABUS), this difference was not statistically significant (p = 0.221). Similarly, ABUS exhibited slightly greater height-width ratios compared to HHUS (median, interquartile range: 0.98, 0.7-1.12 vs. 0.86, 0.74-1.10, p = 0.166). No significant differences were observed in other US findings or tumor sizes between the two modalities (all p > 0.05). Conclusions: Small breast cancers exhibited suspicious US features on both ABUS and HHUS, yet they were assigned lower BI-RADS assessment categories on ABUS compared to HHUS. Therefore, when conducting breast cancer screening with ABUS, it is important to remain attentive to even subtle suspicious findings, and active consideration for biopsy may be warranted.

{"title":"Comparative Analysis of Automated and Handheld Breast Ultrasound Findings for Small (≤1 cm) Breast Cancers Based on BI-RADS Category.","authors":"Han Song Mun, Eun Young Ko, Boo-Kyung Han, Eun Sook Ko, Ji Soo Choi, Haejung Kim, Myoung Kyoung Kim, Jieun Kim","doi":"10.3390/diagnostics15020212","DOIUrl":"10.3390/diagnostics15020212","url":null,"abstract":"<p><p><b>Objectives</b>: This study aimed to compare ultrasound (US) findings between automated and handheld breast ultrasound (ABUS and HHUS, respectively) in small breast cancers, based on the breast imaging reporting and data system (BI-RADS) category. <b>Methods</b>: We included 51 women (mean age: 52 years; range: 39-66 years) with breast cancer (invasive or DCIS), all of whom underwent both ABUS and HHUS. Patients with tumors measuring ≤1 cm on either modality were enrolled. Two breast radiologists retrospectively evaluated multiple imaging features, including shape, orientation, margin, echo pattern, and posterior characteristics and assigned BI-RADS categories. Lesion sizes were compared between US and pathological findings. Statistical analyses were performed using Bowker's test of symmetry, a paired <i>t</i>-test, and a cumulative link mixed model. <b>Results</b>: ABUS assigned lower BI-RADS categories than HHUS while still maintaining malignancy suspicion in categories 4A or higher (54.8% consistent with HHUS; 37.3% downcategorized in ABUS, <i>p</i> = 0.005). While ABUS demonstrated less aggressive margins in some cases (61.3% consistent with HHUS; 25.8% showing fewer suspicious margins in ABUS), this difference was not statistically significant (<i>p</i> = 0.221). Similarly, ABUS exhibited slightly greater height-width ratios compared to HHUS (median, interquartile range: 0.98, 0.7-1.12 vs. 0.86, 0.74-1.10, <i>p</i> = 0.166). No significant differences were observed in other US findings or tumor sizes between the two modalities (all <i>p</i> > 0.05). <b>Conclusions</b>: Small breast cancers exhibited suspicious US features on both ABUS and HHUS, yet they were assigned lower BI-RADS assessment categories on ABUS compared to HHUS. Therefore, when conducting breast cancer screening with ABUS, it is important to remain attentive to even subtle suspicious findings, and active consideration for biopsy may be warranted.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"15 2","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11763899/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143037413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine Learning-Based Alzheimer's Disease Stage Diagnosis Utilizing Blood Gene Expression and Clinical Data: A Comparative Investigation.
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-17 DOI: 10.3390/diagnostics15020211
Manash Sarma, Subarna Chatterjee
<p><p><b>Background/Objectives:</b> This study presents a comparative analysis of the multistage diagnosis of Alzheimer's disease (AD), including mild cognitive impairment (MCI), utilizing two distinct types of biomarkers: blood gene expression and clinical biomarker samples. Both of these samples, obtained from participants in the Alzheimer's Disease Neuroimaging Initiative (ADNI), were independently analyzed utilizing machine learning (ML)-based multiclassifiers. This study applied novel machine learning-based data augmentation techniques to gene expression profile data that are high-dimensional, low-sample-size (HDLSS) and inherently highly imbalanced. The investigation obtained the highest multiclassification performance to date in the multistage diagnosis of Alzheimer's disease utilizing the blood gene expression profiles of Alzheimer's Disease Neuroimaging Initiative (ADNI) participants. Based on the performance results obtained, and other factors such as early prediction capabilities, this study compares the efficacies of the two types of biomarkers for multistage diagnosis. This study presents the sole investigation in which multiclassification-based AD stage diagnosis was conducted utilizing blood gene expression data. We obtained the best multiclassification result in both modalities of the ADNI data in terms of F1-score and were able to identify new genetic biomarkers. <b>Methods:</b> The combination of the XGBoost and SFBS (Sequential Floating Backward Selection) methods was used to select the features. We were able to select the 95 most effective gene probe sets out of 49,386. For the clinical study data, eight of the most effective biomarkers were selected using SFBS. A deep learning (DL) classifier was used to identify the stages-cognitive normal (CN), mild cognitive impairment (MCI), and Alzheimer's disease (AD)/dementia. DL, support vector machine (SVM), gradient boosting (GB), and random forest (RF) classifiers were used for the AD stage detection from gene expression profile data. Because of the high data imbalance in genomic data, borderline oversampling/data augmentation was applied in the model training and original samples for validation. <b>Results:</b> Utilizing clinical data, the highest ROC AUC scores attained were 0.989, 0.927, and 0.907 for the identification of the CN, MCI, and dementia stages, respectively. The highest F1 scores achieved were 0.971, 0.939, and 0.886. Employing gene expression data, we obtained ROC AUC scores of 0.763, 0.761, and 0.706 for the CN, MCI, and dementia stages, respectively, and F1 scores of 0.71, 0.77, and 0.53 for CN, MCI, and dementia, respectively. <b>Conclusions:</b> This represents the best outcome to date for AD stage diagnosis from ADNI blood gene expression profile data utilizing multiclassification techniques. The results indicated that our multiclassification model effectively manages the imbalanced data of a high-dimension, low-sample-size (HDLSS) nature to identify samples of
{"title":"Machine Learning-Based Alzheimer's Disease Stage Diagnosis Utilizing Blood Gene Expression and Clinical Data: A Comparative Investigation.","authors":"Manash Sarma, Subarna Chatterjee","doi":"10.3390/diagnostics15020211","DOIUrl":"10.3390/diagnostics15020211","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;b&gt;Background/Objectives:&lt;/b&gt; This study presents a comparative analysis of the multistage diagnosis of Alzheimer's disease (AD), including mild cognitive impairment (MCI), utilizing two distinct types of biomarkers: blood gene expression and clinical biomarker samples. Both of these samples, obtained from participants in the Alzheimer's Disease Neuroimaging Initiative (ADNI), were independently analyzed utilizing machine learning (ML)-based multiclassifiers. This study applied novel machine learning-based data augmentation techniques to gene expression profile data that are high-dimensional, low-sample-size (HDLSS) and inherently highly imbalanced. The investigation obtained the highest multiclassification performance to date in the multistage diagnosis of Alzheimer's disease utilizing the blood gene expression profiles of Alzheimer's Disease Neuroimaging Initiative (ADNI) participants. Based on the performance results obtained, and other factors such as early prediction capabilities, this study compares the efficacies of the two types of biomarkers for multistage diagnosis. This study presents the sole investigation in which multiclassification-based AD stage diagnosis was conducted utilizing blood gene expression data. We obtained the best multiclassification result in both modalities of the ADNI data in terms of F1-score and were able to identify new genetic biomarkers. &lt;b&gt;Methods:&lt;/b&gt; The combination of the XGBoost and SFBS (Sequential Floating Backward Selection) methods was used to select the features. We were able to select the 95 most effective gene probe sets out of 49,386. For the clinical study data, eight of the most effective biomarkers were selected using SFBS. A deep learning (DL) classifier was used to identify the stages-cognitive normal (CN), mild cognitive impairment (MCI), and Alzheimer's disease (AD)/dementia. DL, support vector machine (SVM), gradient boosting (GB), and random forest (RF) classifiers were used for the AD stage detection from gene expression profile data. Because of the high data imbalance in genomic data, borderline oversampling/data augmentation was applied in the model training and original samples for validation. &lt;b&gt;Results:&lt;/b&gt; Utilizing clinical data, the highest ROC AUC scores attained were 0.989, 0.927, and 0.907 for the identification of the CN, MCI, and dementia stages, respectively. The highest F1 scores achieved were 0.971, 0.939, and 0.886. Employing gene expression data, we obtained ROC AUC scores of 0.763, 0.761, and 0.706 for the CN, MCI, and dementia stages, respectively, and F1 scores of 0.71, 0.77, and 0.53 for CN, MCI, and dementia, respectively. &lt;b&gt;Conclusions:&lt;/b&gt; This represents the best outcome to date for AD stage diagnosis from ADNI blood gene expression profile data utilizing multiclassification techniques. The results indicated that our multiclassification model effectively manages the imbalanced data of a high-dimension, low-sample-size (HDLSS) nature to identify samples of","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"15 2","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11765009/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143037599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differentiation of Early Sacroiliitis Using Machine-Learning- Supported Texture Analysis.
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-17 DOI: 10.3390/diagnostics15020209
Qingqing Zhu, Qi Wang, Xi Hu, Xin Dang, Xiaojing Yu, Liye Chen, Hongjie Hu
<p><p><b>Objectives:</b> We wished to compare the diagnostic performance of texture analysis (TA) against that of a visual qualitative assessment in identifying early sacroiliitis (nr-axSpA). <b>Methods:</b> A total of 92 participants were retrospectively included at our university hospital institution, comprising 30 controls and 62 patients with axSpA, including 32 with nr-axSpA and 30 with r-axSpA, who underwent MR examination of the sacroiliac joints. MRI at 3T of the lumbar spine and the sacroiliac joint was performed using oblique T1-weighted (W), fluid-sensitive, fat-saturated (Fs) T2WI images. The modified New York criteria for AS were used. Patients were classified into the nr-axSpA group if their digital radiography (DR) and/or CT results within 7 days from the MR examination showed a DR and/or CT grade < 2 for the bilateral sacroiliac joints or a DR and/or CT grade < 3 for the unilateral sacroiliac joint. Patients were classified into the r-axSpA group if their DR and/or CT grade was 2 to 3 for the bilateral sacroiliac joints or their DR and/or CT grade was 3 for the unilateral sacroiliac joint. Patients were considered to have a confirmed diagnosis if their DR or CT grade was 4 for the sacroiliac joints and were thereby excluded. A control group of healthy individuals matched in terms of age and sex to the patients was included in this study. First, two readers independently qualitatively scored the oblique coronal T1WI and FsT2WI non-enhanced sacroiliac joint images. The diagnostic efficacies of the two readers were judged and compared using an assigned Likert score, conducting a Kappa consistency test of the diagnostic results between two readers. Texture analysis models (the T1WI-TA model and the FsT2WI-TA model) were constructed through feature extraction and feature screening. The qualitative and quantitative results were evaluated for their diagnostic performance and compared against a clinical reference standard. <b>Results:</b> The qualitative scores of the two readers could significantly distinguish between the healthy controls and the nr-axSpA group and the nr-axSpA and r-axSpA groups (both <i>p</i> < 0.05). Both TA models could significantly distinguish between the healthy controls and the nr-axSpA group and the nr-axSpA group and the r-axSpA group (both <i>p</i> < 0.05). There was no significant difference in the differential diagnoses of the two TA models between the healthy controls and the nr-axSpA group (AUC: 0.934 vs. 0.976; <i>p</i> = 0.1838) and between the nr-axSpA and r-axSpA groups (AUC: 0.917 vs. 0.848; <i>p</i> = 0.2592). In terms of distinguishing between the healthy control and nr-axSpA groups, both the TA models were superior to the qualitative scores of the two readers (all <i>p</i> < 0.05). In terms of distinguishing between the nr-axSpA and r-axSpA groups, the T1WI-TA model was superior to the qualitative scores of the two readers (<i>p</i> = 0.023 and <i>p</i> = 0.007), whereas there was no significant di
{"title":"Differentiation of Early Sacroiliitis Using Machine-Learning- Supported Texture Analysis.","authors":"Qingqing Zhu, Qi Wang, Xi Hu, Xin Dang, Xiaojing Yu, Liye Chen, Hongjie Hu","doi":"10.3390/diagnostics15020209","DOIUrl":"10.3390/diagnostics15020209","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;b&gt;Objectives:&lt;/b&gt; We wished to compare the diagnostic performance of texture analysis (TA) against that of a visual qualitative assessment in identifying early sacroiliitis (nr-axSpA). &lt;b&gt;Methods:&lt;/b&gt; A total of 92 participants were retrospectively included at our university hospital institution, comprising 30 controls and 62 patients with axSpA, including 32 with nr-axSpA and 30 with r-axSpA, who underwent MR examination of the sacroiliac joints. MRI at 3T of the lumbar spine and the sacroiliac joint was performed using oblique T1-weighted (W), fluid-sensitive, fat-saturated (Fs) T2WI images. The modified New York criteria for AS were used. Patients were classified into the nr-axSpA group if their digital radiography (DR) and/or CT results within 7 days from the MR examination showed a DR and/or CT grade &lt; 2 for the bilateral sacroiliac joints or a DR and/or CT grade &lt; 3 for the unilateral sacroiliac joint. Patients were classified into the r-axSpA group if their DR and/or CT grade was 2 to 3 for the bilateral sacroiliac joints or their DR and/or CT grade was 3 for the unilateral sacroiliac joint. Patients were considered to have a confirmed diagnosis if their DR or CT grade was 4 for the sacroiliac joints and were thereby excluded. A control group of healthy individuals matched in terms of age and sex to the patients was included in this study. First, two readers independently qualitatively scored the oblique coronal T1WI and FsT2WI non-enhanced sacroiliac joint images. The diagnostic efficacies of the two readers were judged and compared using an assigned Likert score, conducting a Kappa consistency test of the diagnostic results between two readers. Texture analysis models (the T1WI-TA model and the FsT2WI-TA model) were constructed through feature extraction and feature screening. The qualitative and quantitative results were evaluated for their diagnostic performance and compared against a clinical reference standard. &lt;b&gt;Results:&lt;/b&gt; The qualitative scores of the two readers could significantly distinguish between the healthy controls and the nr-axSpA group and the nr-axSpA and r-axSpA groups (both &lt;i&gt;p&lt;/i&gt; &lt; 0.05). Both TA models could significantly distinguish between the healthy controls and the nr-axSpA group and the nr-axSpA group and the r-axSpA group (both &lt;i&gt;p&lt;/i&gt; &lt; 0.05). There was no significant difference in the differential diagnoses of the two TA models between the healthy controls and the nr-axSpA group (AUC: 0.934 vs. 0.976; &lt;i&gt;p&lt;/i&gt; = 0.1838) and between the nr-axSpA and r-axSpA groups (AUC: 0.917 vs. 0.848; &lt;i&gt;p&lt;/i&gt; = 0.2592). In terms of distinguishing between the healthy control and nr-axSpA groups, both the TA models were superior to the qualitative scores of the two readers (all &lt;i&gt;p&lt;/i&gt; &lt; 0.05). In terms of distinguishing between the nr-axSpA and r-axSpA groups, the T1WI-TA model was superior to the qualitative scores of the two readers (&lt;i&gt;p&lt;/i&gt; = 0.023 and &lt;i&gt;p&lt;/i&gt; = 0.007), whereas there was no significant di","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"15 2","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11763746/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143036763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Marked Gingival Overgrowth Protruding from the Oral Cavity Due to Sodium Valproate.
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-17 DOI: 10.3390/diagnostics15020205
Mami Uegami, Hiroaki Ito, Tadashi Shiohama

Drug-induced gingival overgrowth is associated with various systemic diseases, including epilepsy. Among antiepileptic medications, phenytoin is commonly reported to cause this condition. In contrast, sodium valproate (VPA), another widely used antiepileptic drug, rarely induces gingival overgrowth. This difference in side effects highlights the variability in drug-induced oral complications among different antiepileptic medications. This case study presents a patient who developed significant gingival overgrowth after using VPA for over 10 years. The study aims to identify VPA as the causative agent and observe changes during long-term administration and after dose reduction. Our findings demonstrate that even long-standing gingival overgrowth can improve rapidly following discontinuation of the causative medication, providing valuable insights for managing similar cases in the future.

{"title":"Marked Gingival Overgrowth Protruding from the Oral Cavity Due to Sodium Valproate.","authors":"Mami Uegami, Hiroaki Ito, Tadashi Shiohama","doi":"10.3390/diagnostics15020205","DOIUrl":"10.3390/diagnostics15020205","url":null,"abstract":"<p><p>Drug-induced gingival overgrowth is associated with various systemic diseases, including epilepsy. Among antiepileptic medications, phenytoin is commonly reported to cause this condition. In contrast, sodium valproate (VPA), another widely used antiepileptic drug, rarely induces gingival overgrowth. This difference in side effects highlights the variability in drug-induced oral complications among different antiepileptic medications. This case study presents a patient who developed significant gingival overgrowth after using VPA for over 10 years. The study aims to identify VPA as the causative agent and observe changes during long-term administration and after dose reduction. Our findings demonstrate that even long-standing gingival overgrowth can improve rapidly following discontinuation of the causative medication, providing valuable insights for managing similar cases in the future.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"15 2","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11765381/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143037129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hydrolethalus Syndrome: A Case of a Rare Congenital Disorder.
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-17 DOI: 10.3390/diagnostics15020202
Valerica Belengeanu, Diana Marian, Horia Ademir Stana, Carolina Cojocariu, Cristina Popescu, Ioana Elena Lile

This is a fatal case of multiple complicated congenital anomalies displaying several symptoms consistent with hydrolethalus syndrome. The newborn's phenotype is characterized by a combination of serious anatomical abnormalities such as open-book cerebral hemispheres, defective lobulation of the lungs (one lobe on the left, two on the right), a smaller right kidney, a smooth cerebral surface, and a specific keyhole-shaped defect in the skull base, primarily associated with hydrocephalus.

{"title":"Hydrolethalus Syndrome: A Case of a Rare Congenital Disorder.","authors":"Valerica Belengeanu, Diana Marian, Horia Ademir Stana, Carolina Cojocariu, Cristina Popescu, Ioana Elena Lile","doi":"10.3390/diagnostics15020202","DOIUrl":"10.3390/diagnostics15020202","url":null,"abstract":"<p><p>This is a fatal case of multiple complicated congenital anomalies displaying several symptoms consistent with hydrolethalus syndrome. The newborn's phenotype is characterized by a combination of serious anatomical abnormalities such as open-book cerebral hemispheres, defective lobulation of the lungs (one lobe on the left, two on the right), a smaller right kidney, a smooth cerebral surface, and a specific keyhole-shaped defect in the skull base, primarily associated with hydrocephalus.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"15 2","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11765131/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143037439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Depression Detection and Diagnosis Based on Electroencephalogram (EEG) Analysis: A Systematic Review.
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-17 DOI: 10.3390/diagnostics15020210
Kholoud Elnaggar, Mostafa M El-Gayar, Mohammed Elmogy

Background: Mental disorders are disturbances of brain functions that cause cognitive, affective, volitional, and behavioral functions to be disrupted to varying degrees. One of these disorders is depression, a significant factor contributing to the increase in suicide cases worldwide. Consequently, depression has become a significant public health issue globally. Electroencephalogram (EEG) data can be utilized to diagnose mild depression disorder (MDD), offering valuable insights into the pathophysiological mechanisms underlying mental disorders and enhancing the understanding of MDD. Methods: This survey emphasizes the critical role of EEG in advancing artificial intelligence (AI)-driven approaches for depression diagnosis. By focusing on studies that integrate EEG with machine learning (ML) and deep learning (DL) techniques, we systematically analyze methods utilizing EEG signals to identify depression biomarkers. The survey highlights advancements in EEG preprocessing, feature extraction, and model development, showcasing how these approaches enhance the diagnostic precision, scalability, and automation of depression detection. Results: This survey is distinguished from prior reviews by addressing their limitations and providing researchers with valuable insights for future studies. It offers a comprehensive comparison of ML and DL approaches utilizing EEG and an overview of the five key steps in depression detection. The survey also presents existing datasets for depression diagnosis and critically analyzes their limitations. Furthermore, it explores future directions and challenges, such as enhancing diagnostic robustness with data augmentation techniques and optimizing EEG channel selection for improved accuracy. The potential of transfer learning and encoder-decoder architectures to leverage pre-trained models and enhance diagnostic performance is also discussed. Advancements in feature extraction methods for automated depression diagnosis are highlighted as avenues for improving ML and DL model performance. Additionally, integrating Internet of Things (IoT) devices with EEG for continuous mental health monitoring and distinguishing between different types of depression are identified as critical research areas. Finally, the review emphasizes improving the reliability and predictability of computational intelligence-based models to advance depression diagnosis. Conclusions: This study will serve as a well-organized and helpful reference for researchers working on detecting depression using EEG signals and provide insights into the future directions outlined above, guiding further advancements in the field.

{"title":"Depression Detection and Diagnosis Based on Electroencephalogram (EEG) Analysis: A Systematic Review.","authors":"Kholoud Elnaggar, Mostafa M El-Gayar, Mohammed Elmogy","doi":"10.3390/diagnostics15020210","DOIUrl":"10.3390/diagnostics15020210","url":null,"abstract":"<p><p><b>Background:</b> Mental disorders are disturbances of brain functions that cause cognitive, affective, volitional, and behavioral functions to be disrupted to varying degrees. One of these disorders is depression, a significant factor contributing to the increase in suicide cases worldwide. Consequently, depression has become a significant public health issue globally. Electroencephalogram (EEG) data can be utilized to diagnose mild depression disorder (MDD), offering valuable insights into the pathophysiological mechanisms underlying mental disorders and enhancing the understanding of MDD. <b>Methods:</b> This survey emphasizes the critical role of EEG in advancing artificial intelligence (AI)-driven approaches for depression diagnosis. By focusing on studies that integrate EEG with machine learning (ML) and deep learning (DL) techniques, we systematically analyze methods utilizing EEG signals to identify depression biomarkers. The survey highlights advancements in EEG preprocessing, feature extraction, and model development, showcasing how these approaches enhance the diagnostic precision, scalability, and automation of depression detection. <b>Results:</b> This survey is distinguished from prior reviews by addressing their limitations and providing researchers with valuable insights for future studies. It offers a comprehensive comparison of ML and DL approaches utilizing EEG and an overview of the five key steps in depression detection. The survey also presents existing datasets for depression diagnosis and critically analyzes their limitations. Furthermore, it explores future directions and challenges, such as enhancing diagnostic robustness with data augmentation techniques and optimizing EEG channel selection for improved accuracy. The potential of transfer learning and encoder-decoder architectures to leverage pre-trained models and enhance diagnostic performance is also discussed. Advancements in feature extraction methods for automated depression diagnosis are highlighted as avenues for improving ML and DL model performance. Additionally, integrating Internet of Things (IoT) devices with EEG for continuous mental health monitoring and distinguishing between different types of depression are identified as critical research areas. Finally, the review emphasizes improving the reliability and predictability of computational intelligence-based models to advance depression diagnosis. <b>Conclusions:</b> This study will serve as a well-organized and helpful reference for researchers working on detecting depression using EEG signals and provide insights into the future directions outlined above, guiding further advancements in the field.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"15 2","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11765027/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143037541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep Transfer Learning for Classification of Late Gadolinium Enhancement Cardiac MRI Images into Myocardial Infarction, Myocarditis, and Healthy Classes: Comparison with Subjective Visual Evaluation.
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-17 DOI: 10.3390/diagnostics15020207
Amani Ben Khalifa, Manel Mili, Mezri Maatouk, Asma Ben Abdallah, Mabrouk Abdellali, Sofiene Gaied, Azza Ben Ali, Yassir Lahouel, Mohamed Hedi Bedoui, Ahmed Zrig

Background/Objectives: To develop a computer-aided diagnosis (CAD) method for the classification of late gadolinium enhancement (LGE) cardiac MRI images into myocardial infarction (MI), myocarditis, and healthy classes using a fine-tuned VGG16 model hybridized with multi-layer perceptron (MLP) (VGG16-MLP) and assess our model's performance in comparison to various pre-trained base models and MRI readers. Methods: This study included 361 LGE images for MI, 222 for myocarditis, and 254 for the healthy class. The left ventricle was extracted automatically using a U-net segmentation model on LGE images. Fine-tuned VGG16 was performed for feature extraction. A spatial attention mechanism was implemented as a part of the neural network architecture. The MLP architecture was used for the classification. The evaluation metrics were calculated using a separate test set. To compare the VGG16 model's performance in feature extraction, various pre-trained base models were evaluated: VGG19, DenseNet121, DenseNet201, MobileNet, InceptionV3, and InceptionResNetV2. The Support Vector Machine (SVM) classifier was evaluated and compared to MLP for the classification task. The performance of the VGG16-MLP model was compared with a subjective visual analysis conducted by two blinded independent readers. Results: The VGG16-MLP model allowed high-performance differentiation between MI, myocarditis, and healthy LGE cardiac MRI images. It outperformed the other tested models with 96% accuracy, 97% precision, 96% sensitivity, and 96% F1-score. Our model surpassed the accuracy of Reader 1 by 27% and Reader 2 by 17%. Conclusions: Our study demonstrated that the VGG16-MLP model permits accurate classification of MI, myocarditis, and healthy LGE cardiac MRI images and could be considered a reliable computer-aided diagnosis approach specifically for radiologists with limited experience in cardiovascular imaging.

{"title":"Deep Transfer Learning for Classification of Late Gadolinium Enhancement Cardiac MRI Images into Myocardial Infarction, Myocarditis, and Healthy Classes: Comparison with Subjective Visual Evaluation.","authors":"Amani Ben Khalifa, Manel Mili, Mezri Maatouk, Asma Ben Abdallah, Mabrouk Abdellali, Sofiene Gaied, Azza Ben Ali, Yassir Lahouel, Mohamed Hedi Bedoui, Ahmed Zrig","doi":"10.3390/diagnostics15020207","DOIUrl":"10.3390/diagnostics15020207","url":null,"abstract":"<p><p><b>Background/Objectives:</b> To develop a computer-aided diagnosis (CAD) method for the classification of late gadolinium enhancement (LGE) cardiac MRI images into myocardial infarction (MI), myocarditis, and healthy classes using a fine-tuned VGG16 model hybridized with multi-layer perceptron (MLP) (VGG16-MLP) and assess our model's performance in comparison to various pre-trained base models and MRI readers. <b>Methods:</b> This study included 361 LGE images for MI, 222 for myocarditis, and 254 for the healthy class. The left ventricle was extracted automatically using a U-net segmentation model on LGE images. Fine-tuned VGG16 was performed for feature extraction. A spatial attention mechanism was implemented as a part of the neural network architecture. The MLP architecture was used for the classification. The evaluation metrics were calculated using a separate test set. To compare the VGG16 model's performance in feature extraction, various pre-trained base models were evaluated: VGG19, DenseNet121, DenseNet201, MobileNet, InceptionV3, and InceptionResNetV2. The Support Vector Machine (SVM) classifier was evaluated and compared to MLP for the classification task. The performance of the VGG16-MLP model was compared with a subjective visual analysis conducted by two blinded independent readers. <b>Results:</b> The VGG16-MLP model allowed high-performance differentiation between MI, myocarditis, and healthy LGE cardiac MRI images. It outperformed the other tested models with 96% accuracy, 97% precision, 96% sensitivity, and 96% F1-score. Our model surpassed the accuracy of Reader 1 by 27% and Reader 2 by 17%. <b>Conclusions:</b> Our study demonstrated that the VGG16-MLP model permits accurate classification of MI, myocarditis, and healthy LGE cardiac MRI images and could be considered a reliable computer-aided diagnosis approach specifically for radiologists with limited experience in cardiovascular imaging.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"15 2","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11765457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143037388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor Markers in Pleural Fluid: A Comprehensive Study on Diagnostic Accuracy.
IF 3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-17 DOI: 10.3390/diagnostics15020204
Vladimir Aleksiev, Daniel Markov, Kristian Bechev

Background/Objectives: Malignant pleural effusions (MPEs) pose a significant challenge in clinical practice and exert a considerable socio-economic burden on the healthcare system, affecting approximately 1 million individuals annually. These effusions are a leading cause of debilitating dyspnea and a diminished quality of life among cancer patients, with distant metastasis to the pleural layers occurring in about 20% of cases during treatment. Methods: A cross-sectional, observational case-control study was conducted on 151 Bulgarian patients with a hydrothorax. The control group included 72 patients with benign diseases, confirmed via biopsy, with 38 having inflammatory and 34 non-inflammatory pleural effusions. The other 79 patients had malignant pleural involvement. These groups are representative of the main types of pleural pathology. Results: The study found that all of the tumor markers, except for PIVKA-II (Protein induced by vitamin K absence-II), showed statistically significant differences between the malignant and non-malignant patient groups, with CAE (carcinoembryonic antigen) and CA19-9 showing the most notable differences. The Receiver Operating Characteristic (ROC) analysis revealed that CA72-4 had the best ability to distinguish between the two groups, while PIVKA was the weakest, with optimal cut-off values for all of the relevant tumor markers being derived using the Youden index. Conclusions: In conclusion, our study highlights the transformative potential of pleural fluid tumor markers as precise and minimally invasive resources for distinguishing malignant from non-malignant pleural effusions. These findings pave the way for improved diagnostic accuracy and personalized clinical management, addressing a critical gap in the care of patients with pleural pathologies.

{"title":"Tumor Markers in Pleural Fluid: A Comprehensive Study on Diagnostic Accuracy.","authors":"Vladimir Aleksiev, Daniel Markov, Kristian Bechev","doi":"10.3390/diagnostics15020204","DOIUrl":"10.3390/diagnostics15020204","url":null,"abstract":"<p><p><b>Background/Objectives</b>: Malignant pleural effusions (MPEs) pose a significant challenge in clinical practice and exert a considerable socio-economic burden on the healthcare system, affecting approximately 1 million individuals annually. These effusions are a leading cause of debilitating dyspnea and a diminished quality of life among cancer patients, with distant metastasis to the pleural layers occurring in about 20% of cases during treatment. <b>Methods</b>: A cross-sectional, observational case-control study was conducted on 151 Bulgarian patients with a hydrothorax. The control group included 72 patients with benign diseases, confirmed via biopsy, with 38 having inflammatory and 34 non-inflammatory pleural effusions. The other 79 patients had malignant pleural involvement. These groups are representative of the main types of pleural pathology. <b>Results</b>: The study found that all of the tumor markers, except for PIVKA-II (Protein induced by vitamin K absence-II), showed statistically significant differences between the malignant and non-malignant patient groups, with CAE (carcinoembryonic antigen) and CA19-9 showing the most notable differences. The Receiver Operating Characteristic (ROC) analysis revealed that CA72-4 had the best ability to distinguish between the two groups, while PIVKA was the weakest, with optimal cut-off values for all of the relevant tumor markers being derived using the Youden index. <b>Conclusions</b>: In conclusion, our study highlights the transformative potential of pleural fluid tumor markers as precise and minimally invasive resources for distinguishing malignant from non-malignant pleural effusions. These findings pave the way for improved diagnostic accuracy and personalized clinical management, addressing a critical gap in the care of patients with pleural pathologies.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"15 2","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11765104/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143036764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Diagnostics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1